Breast Cancer Power Specialized high‑resolution PET imaging for breast cancer staging and monitoring presents a focused entry point for clinics and hospitals treating breast cancer, with potential sales opportunities for scanner upgrades, maintenance contracts, and integration into treatment planning workflows.

Guided Biopsy Potential FDA cleared PET guided biopsy tool offers a complementary product line that can be cross-sold to radiology and surgical departments, expanding the clinical use cases and justifying bundled purchasing with the Naviscan system.

Compact & Mobile The compact, mobile design lowers barriers for adoption in outpatient clinics and breast centers, enabling containerizable demonstrations, pilot programs, and regional sales initiatives in medical imaging markets with space constraints.

Acquisition Momentum Recent asset and IP acquisitions from Gamma Medica indicate a growth mindset and potential for synergistic technology integrations, which can be highlighted in conversations about enhanced capabilities and long‑term roadmap alignment.

Growth Readiness Mid‑sized revenue and lean-team structure suggests targeting efficiently run hospitals and regional imaging centers with value‑based ROI discussions, including service, training, and workflow optimization to accelerate decision cycles.